Culture Wars/Current Controversies

Inside the extraordinary effort to save Trump from covid-19

I’m sure a lot of folks are wishing they hadn’t bothered.

By Damian Paletta  and Yasmeen Abutaleb Washington Post

This article is adapted from “Nightmare Scenario: Inside the Trump Administration’s Response to the Pandemic That Changed History,” which will be published June 29 by HarperCollins.

Health and Human Services Secretary Alex Azar’s phone rang with an urgent request: Could he help someone at the White House obtain an experimental coronavirus treatment, known as a monoclonal antibody?

If Azar could get the drug, what would the White House need to do to make that happen? Azar thought for a moment. It was Oct. 1, 2020, and the drug was still in clinical trials. The Food and Drug Administration would have to make a “compassionate use” exception for its use since it was not yet available to the public. Only about 10 people so far had used it outside of those trials. Azar said of course he would help.

Azar wasn’t told who the drug was for but would later connect the dots. The patient was one of President Donald Trump’s closest advisers: Hope Hicks.


Leave a Reply